Cogent Biosciences Inc.
COGT | NASDAQ
$32.17
+$0.17 (+0.53%)
Sep 22, 2026, 12:20 PM ET · Market open
TTM Period Ending | Q2 2026 Jun 29, 2026 | Q1 2026 Mar 30, 2026 | Q4 2025 Dec 30, 2025 | Q3 2025 Sep 29, 2025 | Q2 2025 Jun 29, 2025 | Q1 2025 Mar 30, 2025 | Q4 2024 Dec 30, 2024 | Q3 2024 Sep 29, 2024 | Q2 2024 Jun 29, 2024 | Q1 2024 Mar 30, 2024 | Q4 2023 Dec 30, 2023 | Q3 2023 Sep 29, 2023 | Q2 2023 Jun 29, 2023 | Q1 2023 Mar 30, 2023 | Q4 2022 Dec 30, 2022 | Q3 2022 Sep 29, 2022 | Q2 2022 Jun 29, 2022 | Q1 2022 Mar 30, 2022 | Q4 2021 Dec 30, 2021 | Q3 2021 Sep 29, 2021 | Q2 2021 Jun 29, 2021 | Q1 2021 Mar 30, 2021 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Net Income | -377.18M | -354.3M | -328.94M | -294.37M | -284.08M | -269.5M | -255.86M | -242.3M | -227.05M | -212.17M | -192.41M | -177.66M | -157.34M | -148.19M | -140.24M | -125.54M | -109.56M | -91.18M | -72.27M | -58.7M | -89.6M | -80.44M |
Depreciation & Amortization | 4.18M | 4.6M | 4.58M | 4.55M | 4.5M | 4.42M | 4.35M | 4.04M | 3.8M | 3.93M | 3.59M | 3.73M | 6.59M | 5.47M | 4.81M | 3.95M | 282K | 199K | 147K | 96K | 170K | 442K |
Stock-Based Compensation | 60.37M | 52.98M | 46.08M | 40.31M | 40.06M | 40.36M | 39.74M | 38.61M | 37.01M | 34.16M | 30.62M | 26.81M | 22.67M | 15.51M | 13.83M | 12.65M | 11.49M | 14.08M | 11.69M | 8.7M | 8.75M | 7.03M |
Other Working Capital | -15.79M | 6.31M | 10.52M | 5.78M | 7.73M | 11.54M | 10.24M | 12.48M | 9.35M | 1.57M | 6.63M | 7.5M | -4.14M | -2.22M | -1.61M | -5.56M | 1.01M | -2.53M | -731K | -1.31M | -2.19M | -4.04M |
Other Non-Cash Items | 30M | 6.01M | 5.82M | -3.15M | -9.48M | -7.18M | -7.62M | -9.31M | -2.2M | -5.52M | -6.87M | -5.11M | -6.87M | -539K | 2.2M | 4.75M | 5.6M | n/a | -343K | 151K | 45.47M | 45.47M |
Deferred Income Tax | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | -7.47M | -7.47M |
Change in Working Capital | -24.92M | 5.9M | 8.01M | 6.75M | 15.38M | 10.12M | 11.6M | 17.67M | 11.17M | 12.96M | 11.44M | 13.28M | -473K | -2.07M | 751K | -5.81M | 2.51M | 1.17M | 2.02M | 2.4M | -833K | -4.35M |
Operating Cash Flow | -307.55M | -284.82M | -264.44M | -245.92M | -233.61M | -221.77M | -207.79M | -191.28M | -177.27M | -166.64M | -153.62M | -138.96M | -135.43M | -129.82M | -118.64M | -110.01M | -89.68M | -75.73M | -58.76M | -47.35M | -43.51M | -39.32M |
Capital Expenditures | -1.7M | -1.46M | -1.55M | -818K | -1.03M | -1.05M | -573K | -813K | -654K | -1.76M | -2.8M | -4.45M | -7.64M | -7.53M | -6.86M | -5.33M | -3.18M | -2.16M | -1.72M | -1.29M | -123K | n/a |
Cash Acquisitions | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | 76.4K | 76.4K | 76.4K | 76.4K | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Purchase of Investments | -835.93M | -821.01M | -687.17M | -304.67M | -100.08M | -182.59M | -255.6M | -293.79M | -386.8M | -362.8M | -348.8M | -327.51M | -363.27M | -236.87M | -177.86M | -148.23M | n/a | n/a | n/a | n/a | n/a | n/a |
Sales Maturities Of Investments | 337.64M | 317.1M | 289.2M | 290.41M | 301.25M | 290.25M | 294.45M | 281.7M | 223.82M | 207.9M | 253.78M | 252.06M | 230M | 180M | 60M | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Other Investing Acitivies | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | -76.4K | -76.4K | -76.4K | -76.4K | n/a | n/a | n/a | n/a | n/a | n/a | n/a | 8.42M | 8.42M |
Investing Cash Flow | -499.99M | -505.36M | -399.53M | -15.09M | 200.15M | 106.61M | 38.28M | -12.91M | -163.63M | -156.66M | -97.82M | -79.9M | -140.91M | -64.39M | -124.72M | -153.56M | -3.18M | -2.16M | -1.72M | -1.29M | 8.3M | 8.42M |
Debt Repayment | 167.91M | 215.13M | 215.13M | 46.99M | 47.22M | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Common Stock Repurchased | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Dividend Paid | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Other Financial Acitivies | -48.95M | -48.9M | -48.18M | 720K | 720K | 720K | 356K | 356K | 1.53M | 1.63M | 1.27M | 1.27M | 1.26M | 1.16M | 1.16M | 1.16M | n/a | n/a | -85K | -8K | 109.92M | 109.92M |
Financial Cash Flow | 861.53M | 905.8M | 878.23M | 289.59M | 72.85M | 25.36M | 214.45M | 214.43M | 214.8M | 377.15M | 163.54M | 163.85M | 163.84M | 163.87M | 163.56M | 201.25M | 200.31M | 38.2M | 37.98M | 122.11M | 231.98M | 232.04M |
Net Cash Flow | 53.57M | 115.21M | 213.85M | 28.25M | 39.38M | -89.8M | 44.94M | 10.24M | -126.1M | 53.85M | -87.91M | -55.01M | -112.5M | -29.09M | -78.54M | -61.07M | 108.71M | -39.69M | -22.51M | 73.47M | 196.76M | 201.14M |
Free Cash Flow | -309.24M | -286.27M | -266M | -246.73M | -234.65M | -222.82M | -208.36M | -192.1M | -177.93M | -168.4M | -156.42M | -143.41M | -143.07M | -137.35M | -125.5M | -115.34M | -92.86M | -77.89M | -60.48M | -48.64M | -43.63M | -39.32M |
Adj. Free Cash Flow | -369.61M | -339.25M | -312.08M | -287.04M | -274.71M | -263.18M | -248.1M | -230.71M | -214.94M | -202.56M | -187.04M | -170.22M | -165.74M | -152.86M | -139.34M | -127.99M | -104.35M | -91.97M | -72.17M | -57.34M | -52.38M | -46.35M |
Maintenance CapEx | -1.7M | -1.46M | -1.55M | -818K | -1.03M | -1.05M | -573K | -813K | -654K | -1.76M | -2.8M | -4.45M | -7.64M | -7.53M | -6.86M | -5.33M | -3.18M | -2.16M | -1.72M | -1.29M | -123K | n/a |
Growth CapEx | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Owner Earnings | -309.24M | -286.27M | -266M | -246.73M | -234.65M | -222.82M | -208.36M | -192.1M | -177.93M | -168.4M | -156.42M | -143.41M | -143.07M | -137.35M | -125.5M | -115.34M | -92.86M | -77.89M | -60.48M | -48.64M | -43.63M | -39.32M |
Add to Watchlist
Select watchlists to add or remove COGT